ืœื•ื ื’

Atreca Inc - It's time to load up. ๐Ÿง™

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.
-20%

If you want not to miss ideas like this one,๐ŸŽฏ subscribe and press a thumb up! ๐Ÿ‘ Have a question? Don't be shy to ask! ๐Ÿค“ Interested to study how to analyze charts, follow me!
BCELbiotechnologyPivot PointsstockpicksStocksSupport and ResistanceTrend Linesyuriidomaranskyi

| disciplined | patient | humble | consistently profitable |
ื’ื ืขืœ:

ื›ืชื‘ ื•ื™ืชื•ืจ